Literature DB >> 33161377

Prevention, screening, assessing and managing of non-adherent behaviour in people with rheumatic and musculoskeletal diseases: systematic reviews informing the 2020 EULAR points to consider.

Valentin Ritschl1, Tanja A Stamm2, Daniel Aletaha3, Johannes W J Bijlsma4, Peter Böhm5, Razvan Dragoi6, Emma Dures7,8, Fernando Estévez-López9, Laure Gossec10,11, Annamaria Iagnocco12, José B Negrón13, Michal Nudel14, Andréa Marques15, Ellen Moholt16, Conni Skrubbeltrang17, Bart Van den Bemt18,19, Kirsten Viktil20,21, Marieke Voshaar22, Loreto Carmona23, Annette de Thurah24,25.   

Abstract

OBJECTIVE: To analyse how non-adherence to prescribed treatments might be prevented, screened, assessed and managed in people with rheumatic and musculoskeletal diseases (RMDs).
METHODS: An overview of systematic reviews (SR) was performed in four bibliographic databases. Research questions focused on: (1) effective interventions or strategies, (2) associated factors, (3) impact of shared decision making and effective communication, (4) practical things to prevent non-adherence, (5) effect of non-adherence on outcome, (6) screening and assessment tools and (7) responsible healthcare providers. The methodological quality of the reviews was assessed using AMSTAR-2. The qualitative synthesis focused on results and on the level of evidence attained from the studies included in the reviews.
RESULTS: After reviewing 9908 titles, the overview included 38 SR on medication, 29 on non-pharmacological interventions and 28 on assessment. Content and quality of the included SR was very heterogeneous. The number of factors that may influence adherence exceed 700. Among 53 intervention studies, 54.7% showed a small statistically significant effect on adherence, and all three multicomponent interventions, including different modes of patient education and delivered by a variety of healthcare providers, showed a positive result in adherence to medication. No single assessment provided a comprehensive measure of adherence to either medication or exercise.
CONCLUSIONS: The results underscore the complexity of non-adherence, its changing pattern and dependence on multi-level factors, the need to involve all stakeholders in all steps, the absence of a gold standard for screening and the requirement of multi-component interventions to manage it. © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Epidemiology; Health services research; Patient Care Team

Year:  2020        PMID: 33161377     DOI: 10.1136/rmdopen-2020-001432

Source DB:  PubMed          Journal:  RMD Open        ISSN: 2056-5933


  8 in total

1.  Pilot Intervention to Improve Medication Adherence among Patients with Systemic Lupus Erythematosus Using Pharmacy Refill Data.

Authors:  Kai Sun; Amanda M Eudy; Jennifer L Rogers; Lisa G Criscione-Schreiber; Rebecca E Sadun; Jayanth Doss; Mithu Maheswaranathan; Ann Cameron Barr; Lena Eder; Amy L Corneli; Hayden B Bosworth; Megan E B Clowse
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-11-05       Impact factor: 5.178

Review 2.  An Overview on Causes of Nonadherence in the Treatment of Rheumatoid Arthritis: Its Effect on Mortality and Ways to Improve Adherence.

Authors:  Tutul Chowdhury; Jui Dutta; Pharlin Noel; Ratul Islam; Gael Gonzalez-Peltier; Samzorna Azad; Malavika Shankar; Aditya Keerthi Rayapureddy; Padmaja Deb Roy; Nicole Gousy; Khondokar N Hassan
Journal:  Cureus       Date:  2022-04-27

3.  Making space for patients' preferences in precision medicine: a qualitative study exploring perspectives of patients with rheumatoid arthritis.

Authors:  Karin Schölin Bywall; Jennifer Viberg Johansson; Inger Erlandsson; Marie Heidenvall; Marta Lason; Bente Appel Esbensen
Journal:  BMJ Open       Date:  2022-06-01       Impact factor: 3.006

4.  Treatment adherence in rheumatic diseases in the bDMARD era-are we underachieving?

Authors:  Filipe Oliveira Pinheiro; Maria Seabra Rato; Isabel Fidalgo; Iva Brito
Journal:  Z Rheumatol       Date:  2022-02-01       Impact factor: 1.372

5.  How Can We Enhance Adherence to Medications in Patients with Systemic Lupus Erythematosus? Results from a Qualitative Study.

Authors:  Sharzad Emamikia; Cidem Gentline; Yvonne Enman; Ioannis Parodis
Journal:  J Clin Med       Date:  2022-03-27       Impact factor: 4.241

6.  EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis.

Authors:  György Nagy; Nadia M T Roodenrijs; Désirée van der Heijde; Jacob M van Laar; Paco M J Welsing; Melinda Kedves; Attila Hamar; Marlies C van der Goes; Alison Kent; Margot Bakkers; Polina Pchelnikova; Etienne Blaas; Ladislav Senolt; Zoltan Szekanecz; Ernest H Choy; Maxime Dougados; Johannes Wg Jacobs; Rinie Geenen; Johannes Wj Bijlsma; Angela Zink; Daniel Aletaha; Leonard Schoneveld; Piet van Riel; Sophie Dumas; Yeliz Prior; Elena Nikiphorou; Gianfranco Ferraccioli; Georg Schett; Kimme L Hyrich; Ulf Mueller-Ladner; Maya H Buch; Iain B McInnes
Journal:  Ann Rheum Dis       Date:  2021-08-18       Impact factor: 19.103

7.  Association between VTE and antibiotic prophylaxis guideline compliance and patient-reported outcomes after total hip and knee arthroplasty: an observational study.

Authors:  Helen Badge; Tim Churches; Justine M Naylor; Wei Xuan; Elizabeth Armstrong; Leeanne Gray; John Fletcher; Iain Gosbell; Chung-Wei Christine Lin; Ian A Harris
Journal:  J Patient Rep Outcomes       Date:  2022-10-12

Review 8.  Effectiveness of Interventions Based on Pain Neuroscience Education on Pain and Psychosocial Variables for Osteoarthritis: A Systematic Review.

Authors:  Leidy Tatiana Ordoñez-Mora; Marco Antonio Morales-Osorio; Ilem D Rosero
Journal:  Int J Environ Res Public Health       Date:  2022-02-23       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.